| |
| |
|
| Insider
Information: |
Lydon Nicholas |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
326,890 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,345,848 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
326,890 |
|
|
| Total
Value |
$12,345,848 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Blueprint Medicines Corp |
BPMC |
|
2023-06-21 |
55,784 |
|
0 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
Director |
2018-04-16 |
271,106 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
55,784 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
53,184 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2022-05-23 |
4 |
OE |
$19.53 |
$213,053 |
D/D |
10,909 |
50,584 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
39,675 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-10-01 |
4 |
AS |
$92.06 |
$913,595 |
D/D |
(9,815) |
37,425 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-09-17 |
4 |
AS |
$80.00 |
$40,000 |
D/D |
(500) |
47,240 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-07-06 |
4 |
AS |
$80.44 |
$2,092,351 |
D/D |
(26,007) |
47,740 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-07-02 |
4 |
AS |
$80.13 |
$226,367 |
D/D |
(2,825) |
73,747 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-07-01 |
4 |
AS |
$80.21 |
$104,273 |
D/D |
(1,300) |
76,572 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
77,872 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-23 |
4 |
AS |
$80.00 |
$32,000 |
D/D |
(400) |
75,622 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-22 |
4 |
AS |
$80.29 |
$1,045,135 |
D/D |
(13,017) |
76,022 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,312 |
89,039 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
87,727 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2019-08-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
107,727 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2019-06-13 |
4 |
AS |
$90.36 |
$2,259,000 |
D/D |
(25,000) |
127,727 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2019-06-12 |
4 |
AS |
$81.96 |
$2,119,162 |
D/D |
(25,000) |
152,727 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Director |
– • – |
2018-04-16 |
4 |
AS |
$84.18 |
$2,866,913 |
D/D |
(33,000) |
271,106 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2018-02-28 |
4 |
AS |
$86.35 |
$2,197,356 |
D/D |
(25,000) |
177,727 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Director |
– • – |
2018-02-15 |
4 |
OE |
$4.55 |
$74,998 |
D/D |
16,483 |
304,106 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2017-03-14 |
4 |
AS |
$39.72 |
$2,803,724 |
D/D |
(70,000) |
202,727 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Director |
– • – |
2017-01-31 |
4 |
B |
$15.00 |
$249,990 |
D/D |
16,666 |
287,623 |
2.39 |
- |
|
| ANAB |
Anaptysbio Inc |
Director |
– • – |
2017-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
203,625 |
270,957 |
0 |
- |
|
| ANAB |
Anaptysbio Inc |
Director |
– • – |
2017-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
67,332 |
|
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2015-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
272,727 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
